Literature DB >> 15145878

Summary of recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction.

G Montalescot1, H R Andersen, D Antoniucci, A Betriu, M J de Boer, L Grip, F J Neumann, M T Rothman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15145878      PMCID： PMC1768273     

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  9 in total

1.  ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty).

Authors:  S C Smith; J T Dove; A K Jacobs; J W Kennedy; D Kereiakes; M J Kern; R E Kuntz; J J Popma; H V Schaff; D O Williams; R J Gibbons; J P Alpert; K A Eagle; D P Faxon; V Fuster; T J Gardner; G Gregoratos; R O Russell; S C Smith
Journal:  J Am Coll Cardiol       Date:  2001-06-15       Impact factor: 24.094

2.  Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.

Authors:  Gregg W Stone; Cindy L Grines; David A Cox; Eulogio Garcia; James E Tcheng; John J Griffin; Giulio Guagliumi; Thomas Stuckey; Mark Turco; John D Carroll; Barry D Rutherford; Alexandra J Lansky
Journal:  N Engl J Med       Date:  2002-03-28       Impact factor: 91.245

3.  Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.

Authors:  G Montalescot; P Barragan; O Wittenberg; P Ecollan; S Elhadad; P Villain; J M Boulenc; M C Morice; L Maillard; M Pansiéri; R Choussat; P Pinton
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

4.  Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction.

Authors:  F J Neumann; A Kastrati; C Schmitt; R Blasini; M Hadamitzky; J Mehilli; M Gawaz; M Schleef; M Seyfarth; J Dirschinger; A Schömig
Journal:  J Am Coll Cardiol       Date:  2000-03-15       Impact factor: 24.094

5.  Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial.

Authors:  Thomas Aversano; Lynnet T Aversano; Eugene Passamani; Genell L Knatterud; Michael L Terrin; David O Williams; Sandra A Forman
Journal:  JAMA       Date:  2002-04-17       Impact factor: 56.272

6.  Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.

Authors:  C P Cannon; C M Gibson; C T Lambrew; D A Shoultz; D Levy; W J French; J M Gore; W D Weaver; W J Rogers; A J Tiefenbrunn
Journal:  JAMA       Date:  2000-06-14       Impact factor: 56.272

7.  Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

Authors:  S J Brener; L A Barr; J E Burchenal; S Katz; B S George; A A Jones; E D Cohen; P C Gainey; H J White; H B Cheek; J W Moses; D J Moliterno; M B Effron; E J Topol
Journal:  Circulation       Date:  1998-08-25       Impact factor: 29.690

8.  Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction. Final results from the Primary Angioplasty Registry.

Authors:  B R Brodie; C L Grines; R Ivanhoe; W Knopf; G Taylor; J O'Keefe; R A Weintraub; L G Berdan; J E Tcheng; L H Woodlief
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

9.  Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis.

Authors:  M Dalby; A Bouzamondo; P Lechat; G Montalescot
Journal:  Circulation       Date:  2003-10-06       Impact factor: 29.690
  9 in total
  2 in total

1.  Randomised comparison of femoral versus radial approach for percutaneous coronary intervention using abciximab in acute myocardial infarction: results of the FARMI trial.

Authors:  Camille Brasselet; Sophie Tassan; Pierre Nazeyrollas; Martial Hamon; Damien Metz
Journal:  Heart       Date:  2007-07-16       Impact factor: 5.994

2.  Outcomes of Primary Percutaneous Coronary Intervention through a Transradial Approach in a Tertiary Care Cardiac Center.

Authors:  Najia A Soomro; Muhammad N Khan; Khalid Naseeb; Mahesh K Batra; Haris Majeed; Usman Bhatti; Tariq Ashraf; Musa Karim
Journal:  Cureus       Date:  2019-12-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.